Resources & Evidence Contact us

601 Results:

Sort By:

Breaking data on the efficacy and cost-effectiveness of an exclusive human milk diet for premature infants to be presented at the American Academy of Pediatrics 2022 National Conference

Type: Press Releases

Topic(s): Company Conferences and Events Cost Savings / Cost Effectiveness

New peer-reviewed study finds vat pasteurization retains molecular structure of naturally occurring bioactive proteins in human donor milk, similar to raw breast milk

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Microbiome Pasteurization Quality & Safety

Prolacta Bioscience recognizes nurses caring for fragile infants every day throughout Neonatal Nurses Week and NICU Awareness Month

Type: Press Releases

Topic(s): Company

Black, Hispanic, Asian babies born very early are less likely to receive lifesaving measures

Type: Prolacta in the News

Topic(s): 22-27 weeks (extremely premature) Clinical Studies Feeding Protocols Growth Healthcare Professionals

Prolacta Bioscience celebrated Breastfeeding Awareness Month by recognizing the commitment of NICU parents to their infants’ health

Type: Press Releases

Topic(s): Company Parents

Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development

Type: Press Releases

Topic(s): Company

Multiple peer-reviewed studies show Prolacta’s 100% human milk-based nutritional fortifiers reduce risk of life-threatening comorbidities in premature infants, compared to cow milk-based nutrition

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies Clinical Studies on Prolact/Humavant CR Company Growth Late-Onset Sepsis Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)

Could human breast milk balance your gut microbiome?

Type: Prolacta in the News

Topic(s): Company Microbiome Probiotics

Prolacta Bioscience introduces its first evidence-based feeding protocol for an exclusive human milk diet in the NICU

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD) Company Early Fortification Feeding Intolerance Feeding Protocols Growth Healthcare Professionals Late-Onset Sepsis Length of hospital stay Long-Term outcomes Necrotizing Entercolitis (NEC) Product Retinopathy of Prematurity (ROP)

Not finding the reference you’re looking for?

Use our main search field or email us at info@prolacta.com